Exome Sequencing of SLC30A2 Identifies Novel Loss- and Gain-of-Function Variants Associated with Breast Cell Dysfunction
The zinc (Zn) transporter ZnT2 ( SLC30A2 ) is expressed in specialized secretory cells including breast, pancreas and prostate, and imports Zn into mitochondria and vesicles. Mutations in SLC30A2 substantially reduce milk Zn concentration ([Zn]) and cause severe Zn deficiency in exclusively breastfe...
Gespeichert in:
Veröffentlicht in: | Journal of mammary gland biology and neoplasia 2015-12, Vol.20 (3-4), p.159-172 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The zinc (Zn) transporter ZnT2 (
SLC30A2
) is expressed in specialized secretory cells including breast, pancreas and prostate, and imports Zn into mitochondria and vesicles. Mutations in
SLC30A2
substantially reduce milk Zn concentration ([Zn]) and cause severe Zn deficiency in exclusively breastfed infants. Recent studies show that ZnT2-null mice have low milk [Zn], in addition to profound defects in mammary gland function during lactation. Here, we used breast milk [Zn] to identify novel non-synonymous ZnT2 variants in a population of lactating women. We also asked whether specific variants induce disturbances in intracellular Zn management or cause cellular dysfunction in mammary epithelial cells. Healthy, breastfeeding women were stratified into quartiles by milk [Zn] and exonic sequencing of
SLC30A2
was performed. We found that 36 % of women tested carried non-synonymous ZnT2 variants, all of whom had milk Zn levels that were distinctly above or below those in women without variants. We identified 12 novel heterozygous variants. Two variants (D
103
E and T
288
S) were identified with high frequency (9 and 16 %, respectively) and expression of T
288
S was associated with a known hallmark of breast dysfunction (elevated milk sodium/potassium ratio). Select variants (A
28
D, K
66
N, Q
71
H, D
103
E, A
105
P, Q
137
H, T
288
S and T
312
K) were characterized in vitro. Compared with wild-type ZnT2, these variants were inappropriately localized, and most resulted in either ‘loss-of-function’ or ‘gain-of-function’, and altered sub-cellular Zn pools, Zn secretion, and cell cycle check-points. Our study indicates that
SLC30A2
variants are common in this population, dysregulate Zn management and can lead to breast cell dysfunction. This suggests that genetic variation in ZnT2 could be an important modifier of infant growth/development and reproductive health/disease. Importantly, milk [Zn] level may serve as a bio-reporter of breast function during lactation. |
---|---|
ISSN: | 1083-3021 1573-7039 |
DOI: | 10.1007/s10911-015-9338-z |